A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

A randomized phase 2 peri-operative (neoadjuvant plus adjuvant) study of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus anti–PD-1 alone in patients with resectable stage III and IV melanoma ...

Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the completion of planned enrollment ...

In this multicenter, open-label, randomized, controlled trial in China, we assigned participants with newly diagnosed Kawasaki disease in a 1:1 ratio to receive prednisolone plus standard treatment or ...

Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued ...

Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced that 20-week study completion data from its head-to-head ...

The aim of this research therefore was to streamline the understanding of typical causal structures in both randomized and nonrandomized clinical trials in oncology, presenting concise guidelines for ...

Patients receiving relaxed or tight potassium supplementation control after CABG show no significant differences in 6-month mortality.

A randomized clinical trial conducted across five countries in 47 pediatric emergency departments, including Ann & Robert H.

Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, presented interim clinical data from the CAMPX Trial at ...